This study is looking at a surgical technique for people with glaucoma (a condition that damages the optic nerve and can lead to vision loss) who are having an Ahmed Glaucoma Valve (AGV) implanted. Researchers want to see if delaying the flow of fluid through the AGV, by using a special stitch called a vicryl ligature, can lead to better outcomes after surgery. You could be eligible if you are at least 18 years old, have glaucoma that isn't well-controlled, and are scheduled for an AGV implant. The study will measure changes in your eye pressure (IOP) at different times over 12 months to see if the new technique is more effective. The current status of this study is unclear.

Study design

This is an observational, randomized study involving 152 participants. Participants will be randomly assigned to receive either the standard AGV implantation or the AGV implantation with the vicryl ligature.

What's involved

Your eye pressure will be measured at day one, week one, and months one, three, six, and twelve after surgery. Clinical data on glaucoma medications and post-operative complications will also be collected.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for 12 months after surgery, with eye pressure measurements taken at specific intervals.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.